Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

Flexible Near-Field Wireless Optoelectronics as Subdermal Implants for Broad Applications in Optogenetics.

Shin G, Gomez AM, Al-Hasani R, Jeong YR, Kim J, Xie Z, Banks A, Lee SM, Han SY, Yoo CJ, Lee JL, Lee SH, Kurniawan J, Tureb J, Guo Z, Yoon J, Park SI, Bang SY, Nam Y, Walicki MC, Samineni VK, Mickle AD, Lee K, Heo SY, McCall JG, Pan T, Wang L, Feng X, Kim TI, Kim JK, Li Y, Huang Y, Gereau RW 4th, Ha JS, Bruchas MR, Rogers JA.

Neuron. 2017 Feb 8;93(3):509-521.e3. doi: 10.1016/j.neuron.2016.12.031. Epub 2017 Jan 26.

2.

Preparation and implementation of optofluidic neural probes for in vivo wireless pharmacology and optogenetics.

McCall JG, Qazi R, Shin G, Li S, Ikram MH, Jang KI, Liu Y, Al-Hasani R, Bruchas MR, Jeong JW, Rogers JA.

Nat Protoc. 2017 Feb;12(2):219-237. doi: 10.1038/nprot.2016.155. Epub 2017 Jan 5.

PMID:
28055036
3.

Stretchable multichannel antennas in soft wireless optoelectronic implants for optogenetics.

Park SI, Shin G, McCall JG, Al-Hasani R, Norris A, Xia L, Brenner DS, Noh KN, Bang SY, Bhatti DL, Jang KI, Kang SK, Mickle AD, Dussor G, Price TJ, Gereau RW 4th, Bruchas MR, Rogers JA.

Proc Natl Acad Sci U S A. 2016 Dec 13;113(50):E8169-E8177. Epub 2016 Nov 28.

4.

A Trigger for Opioid Misuse: Chronic Pain and Stress Dysregulate the Mesolimbic Pathway and Kappa Opioid System.

Massaly N, Morón JA, Al-Hasani R.

Front Neurosci. 2016 Nov 7;10:480. eCollection 2016. Review.

5.

Dynorphin Controls the Gain of an Amygdalar Anxiety Circuit.

Crowley NA, Bloodgood DW, Hardaway JA, Kendra AM, McCall JG, Al-Hasani R, McCall NM, Yu W, Schools ZL, Krashes MJ, Lowell BB, Whistler JL, Bruchas MR, Kash TL.

Cell Rep. 2016 Mar 29;14(12):2774-83. doi: 10.1016/j.celrep.2016.02.069. Epub 2016 Mar 17.

6.

Chemogenetic and Optogenetic Activation of Gαs Signaling in the Basolateral Amygdala Induces Acute and Social Anxiety-Like States.

Siuda ER, Al-Hasani R, McCall JG, Bhatti DL, Bruchas MR.

Neuropsychopharmacology. 2016 Jul;41(8):2011-23. doi: 10.1038/npp.2015.371. Epub 2016 Jan 4.

7.

Architectural Representation of Valence in the Limbic System.

Namburi P, Al-Hasani R, Calhoon GG, Bruchas MR, Tye KM.

Neuropsychopharmacology. 2016 Jun;41(7):1697-715. doi: 10.1038/npp.2015.358. Epub 2015 Dec 9. Review.

8.

Pain and Poppies: The Good, the Bad, and the Ugly of Opioid Analgesics.

Trang T, Al-Hasani R, Salvemini D, Salter MW, Gutstein H, Cahill CM.

J Neurosci. 2015 Oct 14;35(41):13879-88. doi: 10.1523/JNEUROSCI.2711-15.2015. Review.

9.

Optodynamic simulation of β-adrenergic receptor signalling.

Siuda ER, McCall JG, Al-Hasani R, Shin G, Il Park S, Schmidt MJ, Anderson SL, Planer WJ, Rogers JA, Bruchas MR.

Nat Commun. 2015 Sep 28;6:8480. doi: 10.1038/ncomms9480.

10.

Distinct Subpopulations of Nucleus Accumbens Dynorphin Neurons Drive Aversion and Reward.

Al-Hasani R, McCall JG, Shin G, Gomez AM, Schmitz GP, Bernardi JM, Pyo CO, Park SI, Marcinkiewcz CM, Crowley NA, Krashes MJ, Lowell BB, Kash TL, Rogers JA, Bruchas MR.

Neuron. 2015 Sep 2;87(5):1063-77. doi: 10.1016/j.neuron.2015.08.019.

11.

Evidence of CNIH3 involvement in opioid dependence.

Nelson EC, Agrawal A, Heath AC, Bogdan R, Sherva R, Zhang B, Al-Hasani R, Bruchas MR, Chou YL, Demers CH, Carey CE, Conley ED, Fakira AK, Farrer LA, Goate A, Gordon S, Henders AK, Hesselbrock V, Kapoor M, Lynskey MT, Madden PA, Moron JA, Rice JP, Saccone NL, Schwab SG, Shand FL, Todorov AA, Wallace L, Wang T, Wray NR, Zhou X, Degenhardt L, Martin NG, Hariri AR, Kranzler HR, Gelernter J, Bierut LJ, Clark DJ, Montgomery GW.

Mol Psychiatry. 2016 May;21(5):608-14. doi: 10.1038/mp.2015.102. Epub 2015 Aug 4.

12.

CRH Engagement of the Locus Coeruleus Noradrenergic System Mediates Stress-Induced Anxiety.

McCall JG, Al-Hasani R, Siuda ER, Hong DY, Norris AJ, Ford CP, Bruchas MR.

Neuron. 2015 Aug 5;87(3):605-20. doi: 10.1016/j.neuron.2015.07.002. Epub 2015 Jul 23.

13.

Wireless Optofluidic Systems for Programmable In Vivo Pharmacology and Optogenetics.

Jeong JW, McCall JG, Shin G, Zhang Y, Al-Hasani R, Kim M, Li S, Sim JY, Jang KI, Shi Y, Hong DY, Liu Y, Schmitz GP, Xia L, He Z, Gamble P, Ray WZ, Huang Y, Bruchas MR, Rogers JA.

Cell. 2015 Jul 30;162(3):662-74. doi: 10.1016/j.cell.2015.06.058. Epub 2015 Jul 16.

14.

Spatiotemporal control of opioid signaling and behavior.

Siuda ER, Copits BA, Schmidt MJ, Baird MA, Al-Hasani R, Planer WJ, Funderburk SC, McCall JG, Gereau RW 4th, Bruchas MR.

Neuron. 2015 May 20;86(4):923-935. doi: 10.1016/j.neuron.2015.03.066. Epub 2015 Apr 30.

15.

Hippocampal long-term potentiation is disrupted during expression and extinction but is restored after reinstatement of morphine place preference.

Portugal GS, Al-Hasani R, Fakira AK, Gonzalez-Romero JL, Melyan Z, McCall JG, Bruchas MR, Morón JA.

J Neurosci. 2014 Jan 8;34(2):527-38. doi: 10.1523/JNEUROSCI.2838-13.2014.

16.

Fabrication and application of flexible, multimodal light-emitting devices for wireless optogenetics.

McCall JG, Kim TI, Shin G, Huang X, Jung YH, Al-Hasani R, Omenetto FG, Bruchas MR, Rogers JA.

Nat Protoc. 2013 Dec;8(12):2413-2428. doi: 10.1038/nprot.2013.158. Epub 2013 Nov 7.

17.

Exposure to chronic mild stress prevents kappa opioid-mediated reinstatement of cocaine and nicotine place preference.

Al-Hasani R, McCall JG, Bruchas MR.

Front Pharmacol. 2013 Aug 6;4:96. doi: 10.3389/fphar.2013.00096. eCollection 2013.

18.

Locus coeruleus kappa-opioid receptors modulate reinstatement of cocaine place preference through a noradrenergic mechanism.

Al-Hasani R, McCall JG, Foshage AM, Bruchas MR.

Neuropsychopharmacology. 2013 Nov;38(12):2484-97. doi: 10.1038/npp.2013.151. Epub 2013 Jun 21.

19.

Genetic deletion of the adenosine A(2A) receptor prevents nicotine-induced upregulation of α7, but not α4β2* nicotinic acetylcholine receptor binding in the brain.

Metaxas A, Al-Hasani R, Farshim P, Tubby K, Berwick A, Ledent C, Hourani S, Kitchen I, Bailey A.

Neuropharmacology. 2013 Aug;71:228-36. doi: 10.1016/j.neuropharm.2013.03.023. Epub 2013 Apr 11.

PMID:
23583933
20.

Injectable, cellular-scale optoelectronics with applications for wireless optogenetics.

Kim TI, McCall JG, Jung YH, Huang X, Siuda ER, Li Y, Song J, Song YM, Pao HA, Kim RH, Lu C, Lee SD, Song IS, Shin G, Al-Hasani R, Kim S, Tan MP, Huang Y, Omenetto FG, Rogers JA, Bruchas MR.

Science. 2013 Apr 12;340(6129):211-6. doi: 10.1126/science.1232437.

21.

Molecular mechanisms of opioid receptor-dependent signaling and behavior.

Al-Hasani R, Bruchas MR.

Anesthesiology. 2011 Dec;115(6):1363-81. doi: 10.1097/ALN.0b013e318238bba6. Review.

22.

Increased desensitization of dopamine D₂ receptor-mediated response in the ventral tegmental area in the absence of adenosine A(2A) receptors.

Al-Hasani R, Foster JD, Metaxas A, Ledent C, Hourani SM, Kitchen I, Chen Y.

Neuroscience. 2011 Sep 8;190:103-11. doi: 10.1016/j.neuroscience.2011.05.068. Epub 2011 Jun 7.

PMID:
21669258
23.
24.

Mouse strain differences in locomotor, sensitisation and rewarding effect of heroin; association with alterations in MOP-r activation and dopamine transporter binding.

Bailey A, Metaxas A, Al-Hasani R, Keyworth HL, Forster DM, Kitchen I.

Eur J Neurosci. 2010 Feb;31(4):742-53. doi: 10.1111/j.1460-9568.2010.07104.x.

PMID:
20384817

Supplemental Content

Loading ...
Support Center